(Q73398050)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

8

Gluckman E

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1

Robin M

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12748664

2 January 2024

author name string

Guardiola P

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Dombret H

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Baruchel A

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Esperou H

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Ribaud P

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Devergie A

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Socié G

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Gluckman E

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12748664

2 January 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12748664

2 January 2024

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 November 2019

https://www.nature.com/articles/1704027.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12748664

https://www.nature.com/articles/1704027

2 January 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1704027

https://www.nature.com/articles/1704027.pdf

2 January 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1704027

Bone Marrow Transplantation

2 January 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

877-887

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12748664%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704027

3 November 2019

exact match

0 references

cites work

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. The Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

The characteristics and outcome of patients with late relapse acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Changing Trends in Allogeneic Bone Marrow Transplantation for Leukemia in the 1980s

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Early and late complications of bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Risk factors for cytomegalovirus infection after human marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia Project Group of the Swiss Group for Clinical Cancer Research (SAKK)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Cytokine cascades in acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Bone marrow transplantation for pediatric leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Solid cancers after bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data. European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Long-term survival in allogeneic bone marrow transplant recipients following acyclovir prophylaxis for CMV infection. The European Acyclovir for CMV Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Varicella-zoster virus infection after marrow transplantation for aplastic anemia or leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Infection with varicella-zoster virus after marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Bone marrow transplantation: a review of delayed complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Is syndrome "X" another late complication of bone-marrow transplantation? [comment].

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704027

7 January 2021

Cytokines, Cellular & Molecular Therapy

42

3

257

GR Hill

1997

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1704027

European Journal of Cancer & Clinical Oncology

2 January 2024

54

25

S25

DJ Winston

1989

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1704027

La Pediatria medica e chirurgica : Medical and surgical pediatrics

2 January 2024

72

21

157

C Uderzo

2000

1 reference

https://api.crossref.org/works/10.1038/SJ.BMT.1704027